How are ABSI straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the ABSI straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 126.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$247.88 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a ABSI straddle?

The breakeven for the ABSI straddle priced on this page is roughly $8.50 and $13.50 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ABSI market-implied 1-standard-deviation expected move is approximately 36.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current ABSI implied volatility affect this straddle?

ABSI ATM IV is at 126.10% with IV rank near 54.98%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

ABSI Straddle Strategy

ABSI (Absci Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.

ABSI (Absci Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.70B, a beta of 2.46 versus the broader market, a 52-week range of 2.24-11.36, average daily share volume of 5.8M, a public-listing history dating back to 2021, approximately 156 full-time employees. These structural characteristics shape how ABSI stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.46 indicates ABSI has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a straddle on ABSI?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current ABSI snapshot

As of June 29, 2026, spot at $11.30, ATM IV 126.10%, IV rank 54.98%, expected move 36.15%. The straddle on ABSI below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this straddle structure on ABSI specifically: ABSI IV at 126.10% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 36.15% (roughly $4.09 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ABSI expiries trade a higher absolute premium for lower per-day decay. Position sizing on ABSI should anchor to the underlying notional of $11.30 per share and to the trader's directional view on ABSI stock.

ABSI straddle setup

The ABSI straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ABSI near $11.30, the first option leg uses a $11.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ABSI chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ABSI shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$11.00	$1.38
Buy 1	Put	$11.00	$1.13

ABSI straddle risk and reward

Net Premium / Debit: -$250.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$247.88
Breakeven(s): $8.50, $13.50
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

ABSI straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on ABSI. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-99.9%	+$849.00
$2.51	-77.8%	+$599.26
$5.00	-55.7%	+$349.52
$7.50	-33.6%	+$99.78
$10.00	-11.5%	-$149.95
$12.50	+10.6%	-$100.31
$14.99	+32.7%	+$149.43
$17.49	+54.8%	+$399.17
$19.99	+76.9%	+$648.91
$22.49	+99.0%	+$898.65

When traders use straddle on ABSI

Straddles on ABSI are pure-volatility plays that profit from large moves in either direction; traders typically buy ABSI straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

ABSI thesis for this straddle

The market-implied 1-standard-deviation range for ABSI extends from approximately $7.21 on the downside to $15.39 on the upside. A ABSI long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current ABSI IV rank near 54.98% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on ABSI should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ABSI options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ABSI-specific events.

ABSI straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ABSI positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ABSI alongside the broader basket even when ABSI-specific fundamentals are unchanged. Always rebuild the position from current ABSI chain quotes before placing a trade.

Frequently asked questions

What is a straddle on ABSI?: A straddle on ABSI is the straddle strategy applied to ABSI (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With ABSI stock trading near $11.30, the strikes shown on this page are snapped to the nearest listed ABSI chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ABSI straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the ABSI straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 126.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$247.88 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ABSI straddle?: The breakeven for the ABSI straddle priced on this page is roughly $8.50 and $13.50 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ABSI market-implied 1-standard-deviation expected move is approximately 36.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on ABSI?: Straddles on ABSI are pure-volatility plays that profit from large moves in either direction; traders typically buy ABSI straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current ABSI implied volatility affect this straddle?: ABSI ATM IV is at 126.10% with IV rank near 54.98%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.